Stock report · NASDAQ
Cypherpunk Technologies Inc. (CYPH)
…
CYPH stock chart
Key statistics
About Cypherpunk Technologies Inc.
Cypherpunk Technologies Inc. is a company based in Cambridge, Massachusetts, that pursues a digital asset treasury strategy centered on Zcash, a privacy-focused cryptocurrency, and that develops and invests in privacy-enhancing technologies. The company was previously known as Leap Therapeutics and adopted its current name in November 2025.
Alongside the digital asset strategy, the company retains a biotechnology portfolio inherited from Leap Therapeutics, focused on biomarker-targeted antibody therapies for cancer. Its lead antibody, DKN-01, which targets the protein DKK1, has been studied in a Phase 2 trial in colorectal cancer, and a second antibody, FL-501, is in preclinical development.
Cypherpunk Technologies trades on the Nasdaq Capital Market under the ticker CYPH.
Quotes may be delayed. Market data is provided for information only and is not investment advice; see our disclaimer.